MARIA RAMIREZ: Open Payments
NPI 1194109819 · NEWARK, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,147 in 57 payments from 12 companies in 2025. Trend: 2023 $1,456 · 2024 $2,273 · 2025 $1,147
Food & beverage: $1,147
| Company | Payments | Amount |
|---|---|---|
| Braeburn Inc. | 27 | $479 |
| Indivior Inc. | 15 | $267 |
| Gilead Sciences, Inc. | 1 | $125 |
| Stryker Corporation | 4 | $95 |
| Alkermes, Inc. | 2 | $36 |
| Lilly USA, LLC | 2 | $35 |
| Inari Medical, Inc. | 1 | $33 |
| SCILEX PHARMACEUTICALS INC. | 1 | $19 |
| AstraZeneca Pharmaceuticals LP | 1 | $16 |
| GlaxoSmithKline, LLC. | 1 | $15 |
Products named: BRIXADI, SUBLOCADE, FLOWTRIEVER CATHETER, S, Epclusa, VIVITROL, MOUNJARO, ZTLido, BREZTRI.
Industry payments across NJ — which companies pay providers there.
